Cyclophosphamide dose in renal failure. 1978

J Kroener, and M Green

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Kroener, and M Green
January 1975, Acta pharmacologica et toxicologica,
J Kroener, and M Green
January 1975, Journal of pharmaceutical sciences,
J Kroener, and M Green
January 2004, Seminars in dialysis,
J Kroener, and M Green
May 1974, British medical journal,
J Kroener, and M Green
May 2006, Clinical journal of the American Society of Nephrology : CJASN,
J Kroener, and M Green
April 1971, Postgraduate medical journal,
J Kroener, and M Green
February 1974, British medical journal,
J Kroener, and M Green
April 1983, Drug intelligence & clinical pharmacy,
J Kroener, and M Green
June 1980, British journal of clinical pharmacology,
Copied contents to your clipboard!